From Texas Health and Human Services Commission <[email protected]>
Subject Change in Preferred Drug List Status for the Macrolides-Ketolides Drug Class
Date November 13, 2023 2:17 PM
  Links have been removed from this email. Learn more in the FAQ.
  Links have been removed from this email. Learn more in the FAQ.
HHS Logo [ [link removed] ]

Blue Gradient


Change in Preferred Drug List Status for the Macrolides-Ketolides Drug Class

In response to the preferred brand name product Eryped 200 MG/5 ML suspension shortage, HHSC removed the non-preferred status [ [link removed] ] from the generic erythromycin 200 MG/5 ML and E.E.S. 200 MG/5 ML suspension on the preferred drug list. The preferred status of the brand name Eryped 200 MG/5 ML suspension will not change to allow for any existing stock available to be utilized. These changes will allow providers to prescribe the generic erythromycin 200 MG/5 ML and E.E.S. 200 MG/5 ML suspension without requiring a PDL prior authorization and continue accessing necessary medication for clients.

*Other News*

* Policy Regarding Health Benefit Plan Coverage Of Prescription Contraceptive Drugs Finalized, Implements January 2024 [ [link removed] ]
* HHSC publishes the Annual Performance Report for the Prescription Drug Rebate Program Report [ [link removed] ]
* Quarterly Clinical Prior Authorization Assistance Chart Now Available [ [link removed] ]

*Reminders*

* Pharmacy Education Information and Opportunities [ [link removed] ]
* Pharmacy Email Addresses Must Be Current in PEMS [ [link removed] ]








________________________________________________________________________

You have subscribed to get updates about Texas Health and Human Services (HHS). For more information about HHS, please visit our website [ [link removed] ].

________________________________________________________________________

Stay Connected Visit us on Facebook [ [link removed] ] Visit us on YouTube [ [link removed] ] Visit us on Twitter [ [link removed] ] Visit us on Instagram [ [link removed] ] Visit us on Facebook [ [link removed] ]  (en español)  

Bookmark and Share [ [link removed] ]

Subscriber Services
Manage Preferences [ [link removed] ]  |  Unsubscribe [ [link removed] ]  |  Help [ [link removed] ]

________________________________________________________________________

This email was sent to [email protected] using govDelivery Communications Cloud on behalf of: Texas Health and Human Services Commission · 707 17th St, Suite 4000 · Denver, CO 80202 GovDelivery logo [ [link removed] ]
Screenshot of the email generated on import

Message Analysis